Metabolism of lidocaine by liver microsomes from streptozotocin-diabetics rats

Polish Journal of Pharmacology

Volumn 55, Issue 2, 2003, Pages 251-254

  Gawrońska Szklarz, Barbara ^a   Musial, Dawid ^a   Droździk, Marek ^a   Paprota, Bartosz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Experimental diabetes; Lidocaine metabolism; Microsomes

Indexed keywords

CYTOCHROME P450 1A2; CYTOCHROME P450 3A2; DEETHYLLIDOCAINE; LIDOCAINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRIFUGATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME SUBSTRATE; IN VITRO STUDY; LIVER MICROSOME; MALE; NONHUMAN; PHARMACOKINETICS; RAT; STREPTOZOCIN DIABETES;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES MELLITUS, EXPERIMENTAL; LIDOCAINE; LIVER; MALE; MICROSOMES, LIVER; RATS; RATS, WISTAR;

EID: 0038446703     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ackerman M.D., Liebman K.C.: Effect of experimental diabetes on drug metabolism in the rat. Drug Metab. Dispos., 1977, 5, 405-410.
2. Chen Y., Potter J.M., Ravenscroft P.J.: A quick, sensitive high-performance liquid chromatography assay for monoethylglycinxylidide and lignocaine in serum/plasma using solid-phase extraction. Ther. Drug Monit., 1992, 14, 31-321.
3. Chen Y., Potter J.M., Ravenscroft P.J.: High-performance liquid chromatographic method for the simultaneous determination of monoethylglycinxylidide and lignocaine. J. Chromatogr., 1992, 574, 361-364.
4. Dajani R.M., Saheb S.E.: The metabolism transformation of phenylbutazone in the alloxan diabetic rat. Comp. Gen. Pharmac., 1974, 5, 11-21.
5. Daniel W.A., Syrek M., Haduch A.: Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies. Pol. J. Pharmacol., 1999, 51, 435-442.
6. Dixon R.L., Hart L.G., Fouts J.R.: The metabolism of drugs by liver microsomes from alloxan-diabetic rats. J. Pharmacol. Exp. Ther., 1961, 133, 7-11.
7. Fein F.S., Kornstein L.B, Strobeck J.E, Capasso, J.M, Sonnenblick E.H.: Altered myocardial mechanics in diabetic rats. Circ. Res., 1980, 47, 922-933.
8. Gwilt P.R., Nahhas R.R., Tracewell W.G.: The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans. Clin. Pharmacokinet., 1991, 20, 477-490.
9. Kato R., Gillette J.R.: Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes. J. Pharmacol. Exp. Ther., 1965, 150, 285-291.
10. Klasssen C.D., Watkins J.B.: Mechanisms of bile formation, hepatic uptake and biliary excretion. Pharmacol. Rev., 1984, 36, 1-67.
11. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem., 1951, 193, 265-275.
12. Meftah N.M., Skett P.: The role of microsomal phospholipids and their fatty acid composition in the control of hepatic metabolism of lignocaine. Brit. J. Pharmacol., 1989, 98, 1399-1405.
13. Merrida B.A., Davies M.H., Cook D.E.: Alterations in hepatic microsomal drug metabolism and cytochrome P450 proteins in spontaneously hypertensive rats. Pharmacology, 1985, 30, 129-135.
14. Nakamoto T., Oda Y., Imaoka S., Funae Y., Fujimori M.: Effect of phenobarbital on the pharmacokinetics of lidocaine, monoethylglycinxylidide and 3-hydroxylidocaine in the rat: correlation with P450 isoform levels. Drug Metab. Disposition, 1997, 25, 296-299.
15. Oda Y., Imaoka S., Nahahira Y., Asada A.: Metabolism of lidocaine by purified rat liver microsomal cytochrome P450 isoenzymes. Biochem. Pharmacol., 1989, 38, 4439-4444.
16. Omura T., Sato R.: The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 1964, 239, 2370-2378.
17. Pang K.S., Terell J.A., Nelson S.D.: An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation. J. Pharmacokin. Biopharm., 1986, 14, 107-130.
18. Shimojo N., Ishizaki T., Imaoka S.: Changes in amounts of cytochrome P450 isoenzymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozotocin-induced diabetes. Biochem. Pharmacol., 1993, 46, 621-627.
19. Skett P., Joels L.A.: Different effects of acute and chronic diabetes mellitus on hepatic drug metabolism in the rats. Biochem. Pharmacol., 1985, 34, 287-289.
20. Thummel K.E., Schenkman J.B.: Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat. Mol. Pharmacol., 1989, 37, 119-120.
21. Warren B.L., Pak R., Finlayson M., Gontownick L., Sunahara G., Bessward G.: Differential effects of diabetes on microsomal metabolism of various substrates. Biochem. Pharmacol., 1983, 32, 327-335.
22. Watkins J.B., Dykstra T.P.: Alterations in biliary excretory function by streptozotocin-induced diabetes. Drug Metab. Dispos., 1987, 15, 177-183.
23. Wrighton S.A., Stevens J.C.: The human cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol., 1992, 22, 1-21.